Jiangsu Yong'an Pharmaceutical

Jiangsu Yong'an Pharmaceutical is a specialized pharmaceutical manufacturer based in Changzhou, China, focusing on the development and production of Active Pharmaceutical Ingredients (APIs) for metabolic diseases. The company is a leading producer of anti-diabetic agents, particularly sulfonylureas and meglitinides such as Gliclazide, Glimepiride, and Repaglinide. Operating from GMP-compliant facilities, Jiangsu Yong'an provides high-quality bulk drugs to global pharmaceutical formulators. Its business model centers on chemical synthesis excellence and maintaining a robust supply chain for essential generic medications. The company's portfolio also extends to newer classes of hypoglycemic agents and related chemical intermediates. It serves both the domestic Chinese market and international clients across various regions.